NCT01672242View on ClinicalTrials.gov

Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Healthy Adult Volunteers
Interventions
DEVICE

HFNC

Graded high flow nasal cannula oxygen at 10, 20 , 30, and 40 liters per minute (LPM) to each subject and end-expiratory lung volume measured by respiratory inductive plethysmography.

DEVICE

CPAP

Graded contiuous positive airway pressure at 5, 10 , 15, and 20 cm H2O applied to each subject and end-expiratory lung volume measured by respiratory inductive plethysmography.

Trial Locations (1)

21201

University of Maryland School of Medicine, Baltimore

All Listed Sponsors
collaborator

Vapotherm, Inc.

INDUSTRY

lead

University of Maryland, Baltimore

OTHER

NCT01672242 - Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®) | Biotech Hunter | Biotech Hunter